Ali Kazemi Karyani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ali Kazemi Karyani has a total of 372 co-authors. Here are the top co-authors by number of shared publications:
- Satar Rezaei
Research Center for Environmental Determinants of Health, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
13 shared publications - Behzad Karami Matin
Research Center for Environmental Determinants of Health (RCEDH), Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
11 shared publications - Shahin Soltani
Research Center for Environmental Determinants of Health (RCEDH), Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
11 shared publications - Moslem Soofi
Social Development and Health Promotion Research Center, Health Policy and Promotion Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
7 shared publications - Mohammad Hajizadeh
School of Health Administration, Dalhousie University, Halifax, NS, Canada
6 shared publications Behzad Karami Matin
Research Center for Environmental Determinants of Health, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
5 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Taylor & Francis in Risk Management and Healthcare Policy
- Vol. ume 19, 1-14
Valuing Insurance Coverage for Infertility Treatment: A Double-Bounded Contingent Valuation Study in Kermanshah, Iran
Background: Infertility imposes substantial medical, psychological, and financial burdens. Despite recent expansion of insurance coverage for infertility services in Iran, evidence on public willingness to contribute to pooled insurance arrangements remains limited. This study estimated willingness to pay (WTP) for infertility insurance among adults in Kermanshah, western Iran, and identified associated determinants. Methods: A cross-sectional contingent valuation study was conducted among 630 adults recruited via convenience sampling in Kermanshah. WTP for a hypothetical package covering 70% of infertility treatment costs (up to two cycles/year) was elicited using a double-bounded dichotomous choice (DBDC) format (bids: 4,000– 16,000 thousand IRR). Mean WTP was estimated via maximum-likelihood interval-data regression. Sensitivity analyses evaluated gender composition and response certainty. Results: Of 626 valid respondents, 85.5% expressed positive WTP. Acceptance declined monotonically with increasing bids, supporting construct validity. Mean monthly WTP was 11,107 thousand IRR (95% CI: 10,212– 12,003; base) and 11,266 thousand IRR (95% CI: 10,317– 12,216; n=451, adjusted). Higher education (β=3,145.56, P=0.011) and socioeconomic status (β=5,254.04, P< 0.001) predicted greater WTP; government-funding expectations (β=− 5,046.92, P=0.004) and basic insurance (β=− 3,697.27, P=0.050) predicted lower WTP. Certainty-calibrated and gender-balanced analyses confirmed robustness. Conclusion: Adults in Kermanshah expressed substantial support for infertility insurance. Given the single-city convenience sample, generalization requires caution. Findings suggest that affordability, socioeconomic gradients, and public expectations regarding government responsibility should be considered in benefit-package and financing design.
- 1 October 2026
- Published by Taylor & Francis in Risk Management and Healthcare Policy
- Vol. ume 19, 1-14
Open AccessValuing Insurance Coverage for Infertility Treatment: A Double-Bounded Contingent Valuation Study in Kermanshah, Iran
Background: Infertility imposes substantial medical, psychological, and financial burdens. Despite recent expansion of insurance coverage for infertility services in Iran, evidence on public willingness to contribute to pooled insurance arrangements remains limited. This study estimated willingness to pay (WTP) for infertility insurance among adults in Kermanshah, western Iran, and identified associated determinants. Methods: A cross-sectional contingent valuation study was conducted among 630 adults recruited via convenience sampling in Kermanshah. WTP for a hypothetical package covering 70% of infertility treatment costs (up to two cycles/year) was elicited using a double-bounded dichotomous choice (DBDC) format (bids: 4,000– 16,000 thousand IRR). Mean WTP was estimated via maximum-likelihood interval-data regression. Sensitivity analyses evaluated gender composition and response certainty. Results: Of 626 valid respondents, 85.5% expressed positive WTP. Acceptance declined monotonically with increasing bids, supporting construct validity. Mean monthly WTP was 11,107 thousand IRR (95% CI: 10,212– 12,003; base) and 11,266 thousand IRR (95% CI: 10,317– 12,216; n=451, adjusted). Higher education (β=3,145.56, P=0.011) and socioeconomic status (β=5,254.04, P< 0.001) predicted greater WTP; government-funding expectations (β=− 5,046.92, P=0.004) and basic insurance (β=− 3,697.27, P=0.050) predicted lower WTP. Certainty-calibrated and gender-balanced analyses confirmed robustness. Conclusion: Adults in Kermanshah expressed substantial support for infertility insurance. Given the single-city convenience sample, generalization requires caution. Findings suggest that affordability, socioeconomic gradients, and public expectations regarding government responsibility should be considered in benefit-package and financing design.
- Open Access
- 1 December 2025
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 19, 4021-4032
Patient Preferences for Low Back Pain Treatments in Iran: A Discrete Choice Experiment
Low back pain (LBP) is a leading cause of disability worldwide, especially in LMICs like Iran, yet patient preferences for treatment remain unquantified, hindering patient-centered care. This study aimed to investigate and quantify Iranian patients’ preferences for LBP treatment attributes using a discrete choice experiment (DCE). A cross-sectional DCE was conducted involving 331 adult patients in Kermanshah city, western Iran, between July and December 2024. The treatment attributes include pain reduction, risk of recurrence, treatment cost, time required for recovery, and type of treatment. A total of 24 treatment choice sets were developed using a D-efficient design and divided into four blocks. Patient preferences were analyzed using conditional and mixed logit regression models. The study population (N=331) had a mean age of 38.51 years and was 51.06% female. The conditional logit model identified pain reduction as the most influential attribute affecting patient preferences (coefficient = 0.836; 95% Confidence Interval(CI): 0.629 1.042; P< 0.001). A significant preference was observed for non-surgical treatments (coefficient = 0.665; 95% CI: 0.561–0.767; P < 0.001), while higher treatment costs, particularly those exceeding 500 million IRR, were negatively associated with choice (coefficient = –0.751; 95% CI:-0.905 −0.595; P <0.001). The mixed logit model revealed significant heterogeneity in preferences, especially for pain reduction (Standard Deviation(SD) up to 1.352; 95% CI: 0.634 −2.071; P< 0.001), treatment type (SD = 1.827; 95% CI: 1.296–2.358;P< 0.001), and high treatment costs (SD = 1.477; 95% CI: 0.928–2.025; P< 0.001), indicating diverse patient valuations. In contrast, risk of recurrence and recovery time showed less variability across individuals. This study showed strong preferences for pain reduction, affordability, and non-surgical treatments. Significant heterogeneity highlights diverse patient values and the need for individualized, patient-centered care. These findings inform clinical practice and health policy, supporting shared decision-making and improved access to effective, affordable, and non-invasive treatment options in low- and middle-income settings.
- 1 December 2025
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 19, 4021-4032
Open AccessPatient Preferences for Low Back Pain Treatments in Iran: A Discrete Choice Experiment
Low back pain (LBP) is a leading cause of disability worldwide, especially in LMICs like Iran, yet patient preferences for treatment remain unquantified, hindering patient-centered care. This study aimed to investigate and quantify Iranian patients’ preferences for LBP treatment attributes using a discrete choice experiment (DCE). A cross-sectional DCE was conducted involving 331 adult patients in Kermanshah city, western Iran, between July and December 2024. The treatment attributes include pain reduction, risk of recurrence, treatment cost, time required for recovery, and type of treatment. A total of 24 treatment choice sets were developed using a D-efficient design and divided into four blocks. Patient preferences were analyzed using conditional and mixed logit regression models. The study population (N=331) had a mean age of 38.51 years and was 51.06% female. The conditional logit model identified pain reduction as the most influential attribute affecting patient preferences (coefficient = 0.836; 95% Confidence Interval(CI): 0.629 1.042; P< 0.001). A significant preference was observed for non-surgical treatments (coefficient = 0.665; 95% CI: 0.561–0.767; P < 0.001), while higher treatment costs, particularly those exceeding 500 million IRR, were negatively associated with choice (coefficient = –0.751; 95% CI:-0.905 −0.595; P <0.001). The mixed logit model revealed significant heterogeneity in preferences, especially for pain reduction (Standard Deviation(SD) up to 1.352; 95% CI: 0.634 −2.071; P< 0.001), treatment type (SD = 1.827; 95% CI: 1.296–2.358;P< 0.001), and high treatment costs (SD = 1.477; 95% CI: 0.928–2.025; P< 0.001), indicating diverse patient valuations. In contrast, risk of recurrence and recovery time showed less variability across individuals. This study showed strong preferences for pain reduction, affordability, and non-surgical treatments. Significant heterogeneity highlights diverse patient values and the need for individualized, patient-centered care. These findings inform clinical practice and health policy, supporting shared decision-making and improved access to effective, affordable, and non-invasive treatment options in low- and middle-income settings.
- Open Access
- 31 May 2025
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 58 (3) , 326-335
The Role of Time Preferences in Compliance With COVID-19 Preventive Behaviors in Iran: A Quasi-hyperbolic Discounting Approach
Objectives: This study aimed to investigate the role of time preferences in compliance with coronavirus disease 2019 (COVID-19) preventive behaviors in an adult population of Iran.Methods: A web-based questionnaire was utilized to conduct a cross-sectional survey of 672 Iranian adults. The parameters of time preferences were estimated using a quasi-hyperbolic discounting model, and the relationship between COVID-19 preventive behaviors and time preferences was examined using a probit regression model.Results: A significant association was observed between the preventive behaviors of COVID-19 and the levels of patience and present-biased preferences among the study participants. Individuals who exhibited low levels of patience were found to be 12.8 percentage points less inclined to follow preventive behaviors compared to those with high levels of patience. The likelihood of having good preventive behaviors of COVID-19 was found to decrease by 14.3 percentage points among individuals with a present bias as opposed to those with a bias toward future.Conclusions: Patience and present-biased preferences are important determinants of adopting preventive behaviors against COVID-19. These behavioral characteristics should be considered in the design of control and prevention programs. Considering people’s discounting behavior and time (in)consistency in their preferences in the design of COVID-19 policy interventions can provide valuable insights for developing tailored public health policy interventions.
- 31 May 2025
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 58 (3) , 326-335
Open AccessThe Role of Time Preferences in Compliance With COVID-19 Preventive Behaviors in Iran: A Quasi-hyperbolic Discounting Approach
Objectives: This study aimed to investigate the role of time preferences in compliance with coronavirus disease 2019 (COVID-19) preventive behaviors in an adult population of Iran.Methods: A web-based questionnaire was utilized to conduct a cross-sectional survey of 672 Iranian adults. The parameters of time preferences were estimated using a quasi-hyperbolic discounting model, and the relationship between COVID-19 preventive behaviors and time preferences was examined using a probit regression model.Results: A significant association was observed between the preventive behaviors of COVID-19 and the levels of patience and present-biased preferences among the study participants. Individuals who exhibited low levels of patience were found to be 12.8 percentage points less inclined to follow preventive behaviors compared to those with high levels of patience. The likelihood of having good preventive behaviors of COVID-19 was found to decrease by 14.3 percentage points among individuals with a present bias as opposed to those with a bias toward future.Conclusions: Patience and present-biased preferences are important determinants of adopting preventive behaviors against COVID-19. These behavioral characteristics should be considered in the design of control and prevention programs. Considering people’s discounting behavior and time (in)consistency in their preferences in the design of COVID-19 policy interventions can provide valuable insights for developing tailored public health policy interventions.
- Open Access
- 31 August 2023
- Published by Institute of Lifestyle Medicine in Journal of Lifestyle Medicine
- Vol. 13 (2) , 101-109
The Effect of COVID-19 Pandemic on Households’ Utilization of Rehabilitation Services: National Evidence from Iran Health System
Ali Kazemi-Karyani, Shahin Soltani, Satar Rezaei, Kamran Irandoust, Jafar Yahyavi Dizaj. JLM 2023;13:101-9. https://doi.org/10.15280/jlm.2023.13.2.101
- 31 August 2023
- Published by Institute of Lifestyle Medicine in Journal of Lifestyle Medicine
- Vol. 13 (2) , 101-109
Open AccessThe Effect of COVID-19 Pandemic on Households’ Utilization of Rehabilitation Services: National Evidence from Iran Health System
Ali Kazemi-Karyani, Shahin Soltani, Satar Rezaei, Kamran Irandoust, Jafar Yahyavi Dizaj. JLM 2023;13:101-9. https://doi.org/10.15280/jlm.2023.13.2.101
- Open Access
- 30 June 2023
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 14 (3) , 180-187
The COVID-19 pandemic and healthcare utilization in Iran: evidence from an interrupted time series analysis
Objectives: This study aimed to examine the effect of the coronavirus disease 2019 (COVID-19) outbreak on the hospitalization rate, emergency department (ED) visits, and outpatient clinic visits in western Iran.Methods: We collected data on the monthly hospitalization rate, rate of patients referred to the ED, and rate of patients referred to outpatient clinics for a period of 40 months (23 months before and 17 months after the COVID-19 outbreak in Iran) from all 7 public hospitals in the city of Kermanshah. An interrupted time series analysis was conducted to examine the impact of COVID-19 on the outcome variables in this study.Results: A statistically significant decrease of 38.11 hospitalizations per 10,000 population (95% confidence interval [CI], 24.93–51.29) was observed in the first month of the COVID-19 outbreak. The corresponding reductions in ED visits and outpatient visits per 10,000 population were 191.65 (95% CI, 166.63–216.66) and 168.57 (95% CI, 126.41–210.73), respectively. After the initial reduction, significant monthly increases in the hospitalization rate (an increase of 1.81 per 10,000 population), ED visits (an increase of 2.16 per 10,000 population), and outpatient clinic visits (an increase of 5.77 per 10,000 population) were observed during the COVID-19 pandemic.Conclusion: Our study showed that the utilization of outpatient and inpatient services in hospitals and clinics significantly declined after the COVID-19 outbreak, and use of these services did not return to pre-outbreak levels as of June 2021.
- 30 June 2023
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 14 (3) , 180-187
Open AccessThe COVID-19 pandemic and healthcare utilization in Iran: evidence from an interrupted time series analysis
Objectives: This study aimed to examine the effect of the coronavirus disease 2019 (COVID-19) outbreak on the hospitalization rate, emergency department (ED) visits, and outpatient clinic visits in western Iran.Methods: We collected data on the monthly hospitalization rate, rate of patients referred to the ED, and rate of patients referred to outpatient clinics for a period of 40 months (23 months before and 17 months after the COVID-19 outbreak in Iran) from all 7 public hospitals in the city of Kermanshah. An interrupted time series analysis was conducted to examine the impact of COVID-19 on the outcome variables in this study.Results: A statistically significant decrease of 38.11 hospitalizations per 10,000 population (95% confidence interval [CI], 24.93–51.29) was observed in the first month of the COVID-19 outbreak. The corresponding reductions in ED visits and outpatient visits per 10,000 population were 191.65 (95% CI, 166.63–216.66) and 168.57 (95% CI, 126.41–210.73), respectively. After the initial reduction, significant monthly increases in the hospitalization rate (an increase of 1.81 per 10,000 population), ED visits (an increase of 2.16 per 10,000 population), and outpatient clinic visits (an increase of 5.77 per 10,000 population) were observed during the COVID-19 pandemic.Conclusion: Our study showed that the utilization of outpatient and inpatient services in hospitals and clinics significantly declined after the COVID-19 outbreak, and use of these services did not return to pre-outbreak levels as of June 2021.
- 13 March 2023
- Published by Taylor & Francis in Journal of Substance Use
- Vol. 29 (4) , 528-539
Prevalence and intensity of cigarette smoking in Iranian households: measurement of socioeconomic inequality
Cigarette smoking is one of the most important behavioral risk factors for chronic diseases. This study aimed to investigate socioeconomic inequalities in cigarette smoking (CS) among Iranian house...
- 13 March 2023
- Published by Taylor & Francis in Journal of Substance Use
- Vol. 29 (4) , 528-539
Prevalence and intensity of cigarette smoking in Iranian households: measurement of socioeconomic inequality
Cigarette smoking is one of the most important behavioral risk factors for chronic diseases. This study aimed to investigate socioeconomic inequalities in cigarette smoking (CS) among Iranian house...
- Open Access
- 23 February 2023
- Published by Springer Nature in BMC Public Health
- Vol. 23 (1) , 1-13
Socioeconomic inequality in informal payments for health services among Iranian households: a national pooled study
There is limited evidence on the prevalence and socioeconomic inequality in informal payments (IP) of households in the Iranian health system. This study was conducted to investigate the prevalence of IP and related socioeconomic inequalities among Iranian households in all provinces. Data on Household Income and Expenditure Surveys (HIES) for 91,360 households were used to examine the prevalence and inequality in informal health sector payments in the years 2016 to 2018. The Normalized Concentration Index (NC) was used to examine inequality in these payments and the decomposition analysis by the Wagstaff approach was used to determine the share of variables affecting the measured inequality. Of the total households, 7,339 (7.9%) reported IP for using health services. Urban households had higher IP (10%) compared to rural ones (5.42%). Also, the proportion of households with IP in 2016 (11.69%) was higher than in 2017 (9.9%), and 2018 (4.60%). NC for the study population was 0.129, which shows that the prevalence of IP is significantly higher in well-off households. Also, NC was 0.213 (p < 0.0001) and -0.019 for urban and rural areas, respectively (p > 0.05). Decomposition analysis indicated that income, sex of head of household, and the province of residence have the highest positive contribution to measured inequality (with contributions of 156.2, 45.8, and 25.6%, respectively). There are a significant prevalence and inequality in IP in Iran's health system and important variables have shaped it. On the whole, inequality was pro-rich. This may lead to increasing inequality in access to quality services in the country. Our findings showed that previous health policies such as regulatory tools, and the health transformation plan (HTP) have not been able to control IP in the health sector in the desired way. It seems that consumer-side policies focusing on affluent households, and high-risk provinces can play an important role in controlling this phenomenon.
- 23 February 2023
- Published by Springer Nature in BMC Public Health
- Vol. 23 (1) , 1-13
Open AccessSocioeconomic inequality in informal payments for health services among Iranian households: a national pooled study
There is limited evidence on the prevalence and socioeconomic inequality in informal payments (IP) of households in the Iranian health system. This study was conducted to investigate the prevalence of IP and related socioeconomic inequalities among Iranian households in all provinces. Data on Household Income and Expenditure Surveys (HIES) for 91,360 households were used to examine the prevalence and inequality in informal health sector payments in the years 2016 to 2018. The Normalized Concentration Index (NC) was used to examine inequality in these payments and the decomposition analysis by the Wagstaff approach was used to determine the share of variables affecting the measured inequality. Of the total households, 7,339 (7.9%) reported IP for using health services. Urban households had higher IP (10%) compared to rural ones (5.42%). Also, the proportion of households with IP in 2016 (11.69%) was higher than in 2017 (9.9%), and 2018 (4.60%). NC for the study population was 0.129, which shows that the prevalence of IP is significantly higher in well-off households. Also, NC was 0.213 (p < 0.0001) and -0.019 for urban and rural areas, respectively (p > 0.05). Decomposition analysis indicated that income, sex of head of household, and the province of residence have the highest positive contribution to measured inequality (with contributions of 156.2, 45.8, and 25.6%, respectively). There are a significant prevalence and inequality in IP in Iran's health system and important variables have shaped it. On the whole, inequality was pro-rich. This may lead to increasing inequality in access to quality services in the country. Our findings showed that previous health policies such as regulatory tools, and the health transformation plan (HTP) have not been able to control IP in the health sector in the desired way. It seems that consumer-side policies focusing on affluent households, and high-risk provinces can play an important role in controlling this phenomenon.
- Open Access
- 15 July 2022
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 10, 910024
Epidemiology and Economic Burden of an Outbreak of Cyclopeptide-Containing Mushroom Poisoning in the West of Iran
Little evidence is available on the epidemiological and economical dimensions of certain foodborne diseases such as wild mushroom poisoning. This study aimed to investigate the epidemiology and estimate the costs of poisoning with cyclopeptide-containing mushrooms in Kermanshah province in 2018. In this study, poisoning was investigated in different subgroups. The cost of illness method with a bottom-up approach was used to estimate the poisoning costs. Both direct and indirect costs of the poisoning were included in the analysis. The perspective of the study was society. Required data were obtained from the medical records of Imam Khomeini hospital and completed through a line survey with the patients. Two hundred eighty-three patients were poisoned in Kermanshah due to poisoning with cyclopeptide-containing mushrooms. Of 283 patients, 143 (50.53%) were men and 59.01% of patients were rural residents. About 43% of admissions were out-patient cases and ~40% of patients were hospitalized within 1–3 days. Also, eight patients were pronounced dead in the area. The total cost of poisoning with cyclopeptide-containing mushrooms in Kermanshah province was $ 1,259,349.26. Of that, $ 69,281.65 was related to direct medical costs and $ 10,727.23 was direct non-medical costs. The indirect costs of death were estimated to be $ 1,125,829.7. The current study revealed that there is a significant financial burden due to cyclopeptide-containing mushrooms on patients, the health system, and society as a whole. Further studies are recommended to clarify the epidemiological and economic burden of foodborne illnesses related to wild mushroom poisonings. Sharing the outputs with health authorities, and informing the general public are warranted to reduce the burden of such diseases.- 15 July 2022
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 10, 910024
Open AccessEpidemiology and Economic Burden of an Outbreak of Cyclopeptide-Containing Mushroom Poisoning in the West of Iran
Little evidence is available on the epidemiological and economical dimensions of certain foodborne diseases such as wild mushroom poisoning. This study aimed to investigate the epidemiology and estimate the costs of poisoning with cyclopeptide-containing mushrooms in Kermanshah province in 2018. In this study, poisoning was investigated in different subgroups. The cost of illness method with a bottom-up approach was used to estimate the poisoning costs. Both direct and indirect costs of the poisoning were included in the analysis. The perspective of the study was society. Required data were obtained from the medical records of Imam Khomeini hospital and completed through a line survey with the patients. Two hundred eighty-three patients were poisoned in Kermanshah due to poisoning with cyclopeptide-containing mushrooms. Of 283 patients, 143 (50.53%) were men and 59.01% of patients were rural residents. About 43% of admissions were out-patient cases and ~40% of patients were hospitalized within 1–3 days. Also, eight patients were pronounced dead in the area. The total cost of poisoning with cyclopeptide-containing mushrooms in Kermanshah province was $ 1,259,349.26. Of that, $ 69,281.65 was related to direct medical costs and $ 10,727.23 was direct non-medical costs. The indirect costs of death were estimated to be $ 1,125,829.7. The current study revealed that there is a significant financial burden due to cyclopeptide-containing mushrooms on patients, the health system, and society as a whole. Further studies are recommended to clarify the epidemiological and economic burden of foodborne illnesses related to wild mushroom poisonings. Sharing the outputs with health authorities, and informing the general public are warranted to reduce the burden of such diseases. - Open Access
- 6 May 2022
- Published by Springer Nature in BMC Health Services Research
- Vol. 22 (1) , 1-20
Contributing factors to healthcare costs in individuals with autism spectrum disorder: a systematic review
Background: Individuals with autism spectrum disorder (ASD) are more likely to use healthcare than their counterparts without disabilities, which imposes high medical costs to families and health systems. This study aimed to investigate healthcare costs and its determinants among individuals with ASD. Methods: In this systematic review, we searched online databases (Web of Science, Medline through PubMed and Scopus) for observational and experimental studies that included data on service use and costs associated with ASD and published between January 2000 and May 2021. Exclusion criteria included non-English language articles, duplicates, abstracts, qualitative studies, gray literature, and non-original papers (e.g., letters to editors, editorials, reviews, etc.). Results: Our searches yielded 4015 articles screened according to PRISMA guidelines. Of 4015 studies identified, 37 articles from 10 countries were eligible for final inclusion. Therapeutic interventions, outpatient visits and medications constituted the largest proportion of direct medical expenditure on individuals with ASD. Included studies suggest lack of health insurance, having associated morbidities, more severe symptoms, younger age groups and lower socioeconomic status (SES) are associated with higher medical expenditure in individuals with ASD. Conclusions: This systematic review identified a range of factors, including lower SES and lack of health insurance, which are associated with higher healthcare costs in people with ASD. Our study supports the formulation of policy options to reduce financial risks in families of individuals with ASD in countries which do not have a tax-based or universal health coverage system.
- 6 May 2022
- Published by Springer Nature in BMC Health Services Research
- Vol. 22 (1) , 1-20
Open AccessContributing factors to healthcare costs in individuals with autism spectrum disorder: a systematic review
Background: Individuals with autism spectrum disorder (ASD) are more likely to use healthcare than their counterparts without disabilities, which imposes high medical costs to families and health systems. This study aimed to investigate healthcare costs and its determinants among individuals with ASD. Methods: In this systematic review, we searched online databases (Web of Science, Medline through PubMed and Scopus) for observational and experimental studies that included data on service use and costs associated with ASD and published between January 2000 and May 2021. Exclusion criteria included non-English language articles, duplicates, abstracts, qualitative studies, gray literature, and non-original papers (e.g., letters to editors, editorials, reviews, etc.). Results: Our searches yielded 4015 articles screened according to PRISMA guidelines. Of 4015 studies identified, 37 articles from 10 countries were eligible for final inclusion. Therapeutic interventions, outpatient visits and medications constituted the largest proportion of direct medical expenditure on individuals with ASD. Included studies suggest lack of health insurance, having associated morbidities, more severe symptoms, younger age groups and lower socioeconomic status (SES) are associated with higher medical expenditure in individuals with ASD. Conclusions: This systematic review identified a range of factors, including lower SES and lack of health insurance, which are associated with higher healthcare costs in people with ASD. Our study supports the formulation of policy options to reduce financial risks in families of individuals with ASD in countries which do not have a tax-based or universal health coverage system.
- Open Access
- 1 March 2022
- Published by CMV Verlag in WORLD JOURNAL OF PLASTIC SURGERY
- Vol. 11 (1) , 73-80
Inequality in Cosmetic Services and Surgery among Iranian Households in 2019: A Decomposition Analysis
Background The demand for cosmetic surgery is on the rise worldwide, making it the common form of surgery globally while the use of cosmetic surgery being exponentially high in Iran. The aim of this study was to investigate inequality in the use of cosmetic services and surgery (CSS) among Iranian ...
- 1 March 2022
- Published by CMV Verlag in WORLD JOURNAL OF PLASTIC SURGERY
- Vol. 11 (1) , 73-80
Open AccessInequality in Cosmetic Services and Surgery among Iranian Households in 2019: A Decomposition Analysis
Background The demand for cosmetic surgery is on the rise worldwide, making it the common form of surgery globally while the use of cosmetic surgery being exponentially high in Iran. The aim of this study was to investigate inequality in the use of cosmetic services and surgery (CSS) among Iranian ...